Ldlrap1-flox 基因敲除小鼠

1. Abifadel, Marianne, Boileau, Catherine. 2022. Genetic and molecular architecture of familial hypercholesterolemia. In Journal of internal medicine, 293, 144-165. doi:10.1111/joim.13577. https://pubmed.ncbi.nlm.nih.gov/36196022/

2. Tokgozoglu, Lale, Kayikcioglu, Meral. 2021. Familial Hypercholesterolemia: Global Burden and Approaches. In Current cardiology reports, 23, 151. doi:10.1007/s11886-021-01565-5. https://pubmed.ncbi.nlm.nih.gov/34480646/

3. Hajighasemi, Saeideh, Mahdavi Gorabi, Armita, Bianconi, Vanessa, Reiner, Željko, Sahebkar, Amirhossein. 2019. A review of gene- and cell-based therapies for familial hypercholesterolemia. In Pharmacological research, 143, 119-132. doi:10.1016/j.phrs.2019.03.016. https://pubmed.ncbi.nlm.nih.gov/30910740/

4. Ahangari, Najmeh, Sahebkar, Amirhossein, Azimi-Nezhad, Mohsen, Pasdar, Alireza, Ghayour Mobarhan, Majid. 2021. A Novel Splice Site Variant in the LDLRAP1 Gene Causes Familial Hypercholesterolemia. In Iranian biomedical journal, 25, 374-9. doi:10.52547/ibj.25.5.374. https://pubmed.ncbi.nlm.nih.gov/34425670/

5. Leigh, Tani, Kawai, Tatsuo, Preston, Kyle, Scalia, Rosario G, Autieri, Michael V. 2022. Deletion of LDLRAP1 Induces Atherosclerotic Plaque Formation, Insulin Resistance, and Dysregulated Insulin Response in Adipose Tissue. In The American journal of pathology, 192, 1092-1108. doi:10.1016/j.ajpath.2022.03.014. https://pubmed.ncbi.nlm.nih.gov/35460615/